64 related articles for article (PubMed ID: 24033272)
21. Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT.
Giebel S; Labopin M; Potter M; Poiré X; Sengeloev H; Socié G; Huynh A; Afanasyev BV; Schanz U; Ringden O; Kalhs P; Beelen DW; Campos AM; Masszi T; Canaani J; Mohty M; Nagler A
Eur J Cancer; 2018 Jun; 96():73-81. PubMed ID: 29679774
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric analysis of cerebrospinal fluid in adult patients with acute lymphoblastic leukemia during follow-up.
Gong X; Lin D; Wang H; Wang Y; Liu B; Wei H; Zhou C; Liu K; Wei S; Gong B; Zhang G; Liu Y; Zhao X; Li Y; Gu R; Qiu S; Mi Y; Wang J
Eur J Haematol; 2018 Mar; 100(3):279-285. PubMed ID: 29240262
[TBL] [Abstract][Full Text] [Related]
23. High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients.
Pan J; Yang JF; Deng BP; Zhao XJ; Zhang X; Lin YH; Wu YN; Deng ZL; Zhang YL; Liu SH; Wu T; Lu PH; Lu DP; Chang AH; Tong CR
Leukemia; 2017 Dec; 31(12):2587-2593. PubMed ID: 28490811
[TBL] [Abstract][Full Text] [Related]
24. [Chinese guidelines for diagnosis and treatment of acute lymphoblastic leukemia(2016)].
Hematology Oncology Committee, Chinese Anti- Cancer Association; Leukemia & Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association
Zhonghua Xue Ye Xue Za Zhi; 2016 Oct; 37(10):837-845. PubMed ID: 27801310
[No Abstract] [Full Text] [Related]
25. Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis.
Sasaki K; Jabbour EJ; Ravandi F; Short NJ; Thomas DA; Garcia-Manero G; Daver NG; Kadia TM; Konopleva MY; Jain N; Issa GC; Jeanis V; Moore HG; Garris RS; Pemmaraju N; Cortes JE; O'Brien SM; Kantarjian HM
Cancer; 2016 Dec; 122(23):3650-3656. PubMed ID: 27479888
[TBL] [Abstract][Full Text] [Related]
26. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Czyz A; Ottmann O; Baron F; Brissot E; Ciceri F; Cornelissen JJ; Esteve J; Gorin NC; Savani B; Schmid C; Mohty M; Nagler A
Cancer; 2016 Oct; 122(19):2941-51. PubMed ID: 27309127
[TBL] [Abstract][Full Text] [Related]
27. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives.
Malagola M; Papayannidis C; Baccarani M
Ann Hematol; 2016 Apr; 95(5):681-93. PubMed ID: 26891878
[TBL] [Abstract][Full Text] [Related]
29. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
[TBL] [Abstract][Full Text] [Related]
30. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
Jain N; Lamb AV; O'Brien S; Ravandi F; Konopleva M; Jabbour E; Zuo Z; Jorgensen J; Lin P; Pierce S; Thomas D; Rytting M; Borthakur G; Kadia T; Cortes J; Kantarjian HM; Khoury JD
Blood; 2016 Apr; 127(15):1863-9. PubMed ID: 26747249
[TBL] [Abstract][Full Text] [Related]
31. Management and treatment of relapsed or refractory Ph(-) B-precursor ALL: a web-based, double-blind survey of EU clinicians.
Saltman D; Barlev A; Seshagiri D; Katsoulis I; Lin V; Barber B
BMC Cancer; 2015 Oct; 15():771. PubMed ID: 26498125
[TBL] [Abstract][Full Text] [Related]
32. [Outcome of patients with adult acute lymphoblastic leukemia between 2000 and 2013: experience from single center].
Wang J; Jiang B; Liu K; Xu L; Zhang X; Chen H; Jia J; Yang S; Bao L; Jiang H; Lu J; Zhu H; Zhao T; Huang X; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):726-32. PubMed ID: 26462770
[TBL] [Abstract][Full Text] [Related]
33. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies.
van Dongen JJ; van der Velden VH; Brüggemann M; Orfao A
Blood; 2015 Jun; 125(26):3996-4009. PubMed ID: 25999452
[TBL] [Abstract][Full Text] [Related]
34. [Optimal treatment of adult Ph negative acute lymphoblastic leukemia].
Zhao X; Wei H; Lin D; Wang Y; Zhou C; Liu B; Li W; Liu K; Wang H; Li C; Li Q; Gong B; Liu Y; Gong X; Mi Y; Wang J
Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):873-9. PubMed ID: 25339321
[TBL] [Abstract][Full Text] [Related]
35. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E
J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047
[TBL] [Abstract][Full Text] [Related]
36. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.
Larson RA; Dodge RK; Linker CA; Stone RM; Powell BL; Lee EJ; Schulman P; Davey FR; Frankel SR; Bloomfield CD; George SL; Schiffer CA
Blood; 1998 Sep; 92(5):1556-64. PubMed ID: 9716583
[TBL] [Abstract][Full Text] [Related]
37. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.
Berry DA; Zhou S; Higley H; Mukundan L; Fu S; Reaman GH; Wood BL; Kelloff GJ; Jessup JM; Radich JP
JAMA Oncol; 2017 Jul; 3(7):e170580. PubMed ID: 28494052
[TBL] [Abstract][Full Text] [Related]
38. Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol.
Perusini MA; Andrews C; Eshetu AG; Gupta V; Maze D; Yee KWL; Bankar A; Davidson MB; Richard-Carpentier G; Chan SM; Schimmer AD; Sibai J; Alharbi S; Lucero JA; Linn SM; Minden MD; Schuh AC; Sibai H
Leukemia; 2024 Apr; 38(4):912-913. PubMed ID: 38431747
[No Abstract] [Full Text] [Related]
39. Acute lymphoblastic leukemia in older adults: curtain call for conventional chemotherapy?
Luskin MR
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):7-14. PubMed ID: 34889389
[TBL] [Abstract][Full Text] [Related]
40. [Chinese guidelines for diagnosis and treatment of adult acute lymphoblastic leukemia (2021)].
;
Zhonghua Xue Ye Xue Za Zhi; 2021 Sep; 42(9):705-716. PubMed ID: 34753224
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
